Residual viral replication during antiretroviral therapy boosts human immunodeficiency virus type 1-specific CD8(+) T-cell responses in subjects treated early after infection
Gm. Ortiz et al., Residual viral replication during antiretroviral therapy boosts human immunodeficiency virus type 1-specific CD8(+) T-cell responses in subjects treated early after infection, J VIROLOGY, 76(1), 2002, pp. 411-415
Human immunodeficiency virus type 1 (HIV-1)-infected subjects treated early
after infection have preserved HIV-1-specific CD4(+) T-cell function. We s
tudied the effect of highly active antiretroviral therapy (HAART) on the fr
equency of HIV-1-specific CD8(+) T cells in patients treated during early (
n = 31) or chronic (n = 23) infection. The degree of viral suppression and
time of initiation of treatment influenced the magnitude of the CD8+ T-cell
response. HIV-1-specific CD8(+) T cells can increase in number after HAART
in subjects treated early after infection who have episodes of transient v
iremia.